Trademark: 87817100
Word
RIGEL ONE CARE
Status
Registered
Status Code
700
Status Date
Tuesday, July 14, 2020
Serial Number
87817100
Registration Number
6102551
Registration Date
Tuesday, July 14, 2020
Mark Type
4000
Filing Date
Thursday, March 1, 2018
Published for Opposition
Tuesday, September 17, 2019

Trademark Owner History
Rigel Pharmaceuticals, Inc. - Original Registrant

Classifications
36 Advisory services and consultancy regarding healthcare benefits and pharmacy benefits; providing information and guidance in connection with health, medical, and pharmacy insurance benefit plans; insurance consultation services, namely, assisting physician offices and patients to identify the scope of coverage offered by patient medical and pharmaceutical insurance; insurance consultation services, namely, assisting physician offices and patients to obtain prior authorization for medical and pharmaceutical insurance claims and the preparation and submission of related paperwork and assisting physician offices and patients to appeal denial of medical and pharmaceutical insurance claims and the preparation and submission of related paperwork; Financial information, namely, providing reimbursement information, drug pricing, payment tracking, and co-payment information to health care providers, insurers and consumers; Financial administration of health reimbursement arrangements, namely, providing an internet website portal featuring financial information to healthcare professionals, patients and patient caregivers relating to reimbursement for pharmaceutical preparations, health care and prescription drugs
35 Providing a database for collecting and reporting information pertaining to medical treatment, insurance, and prescription drug dispensing and management for business purposes; Business administration of a patient support program, which helps patients, in coordination with their healthcare provider, access, start, and comply with therapy as prescribed, and provides co-pay assistance, assistance with insurance and healthcare providers, coverage and reimbursement information, general education and support, and information about products, health topics, and related resources; Providing business information and billing services in the field of healthcare, namely, providing reimbursement information, drug pricing, payment tracking, co-payment data and other market intelligence to health care providers, insurers and consumers; Providing consumer product information relating to prescription drugs to distributors, pharmacies and consumers; Distribution of product advertising materials for sales representatives of prescription drugs; Assisting patients in enrolling in pharmaceutical reimbursement programs of others; Providing a website featuring information for medical professionals, pharmacies, insurance companies and drug distributors regarding retail pharmacy business information about the administration and dosing of pharmaceuticals; Medical billing support services, namely, providing an internet website portal featuring billing information to healthcare professionals, patients and patient caregivers relating to reimbursement for pharmaceutical preparations, health care and prescription drugs
44 Medical information services; Medical informational services, namely, providing information regarding prescription drugs for drug distributors, insurance companies, pharmacies and medical professionals; Providing a website featuring information for medical professionals, pharmacies, insurance companies and drug distributors regarding therapeutic properties of pharmaceuticals, the treatment of diseases and medical conditions, and medical information about the administration and dosing of pharmaceuticals; Patient support services relating to treatment of medical disorders, namely, providing information relating to therapeutic properties of pharmaceuticals, the treatment of diseases and medical conditions, medical information about the administration and dosing of pharmaceuticals; Providing a website featuring healthcare information, namely, providing resources in the field of pharmaceuticals for treatment of diseases and links to such resources; Medical information services, namely, providing a website in the medical, pharmaceutical and health fields featuring information related to health, wellness, healthcare, patient support services, pharmaceuticals, pharmaceutical access, drug safety and/or drug compatibility in relation to therapy and treatment of individuals, adherence to pharmaceutical protocols, and the diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical care consulting services in the fields of patient treatment and treatment protocols
"CARE"

Trademark Events
Feb 3, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Feb 3, 2023
Teas Change Of Correspondence Received
Feb 3, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Feb 3, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Feb 3, 2023
Teas Change Of Owner Address Received
May 25, 2021
Applicant/Correspondence Changes (Non-Responsive) Entered
May 25, 2021
Teas Change Of Correspondence Received
May 25, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
May 25, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
May 25, 2021
Teas Change Of Owner Address Received
Jul 14, 2020
Registered-Principal Register
Jun 12, 2020
Notice Of Acceptance Of Statement Of Use E-Mailed
Jun 11, 2020
Allowed Principal Register - Sou Accepted
May 19, 2020
Statement Of Use Processing Complete
May 4, 2020
Use Amendment Filed
May 19, 2020
Case Assigned To Intent To Use Paralegal
May 4, 2020
Teas Statement Of Use Received
Nov 12, 2019
Noa E-Mailed - Sou Required From Applicant
Sep 17, 2019
Official Gazette Publication Confirmation E-Mailed
Sep 17, 2019
Published For Opposition
Aug 28, 2019
Notification Of Notice Of Publication E-Mailed
Aug 9, 2019
Assigned To Lie
Jul 31, 2019
Approved For Pub - Principal Register
Jul 30, 2019
Teas/Email Correspondence Entered
Jul 29, 2019
Correspondence Received In Law Office
Jul 29, 2019
Teas Request For Reconsideration Received
May 13, 2019
Teas Change Of Correspondence Received
Jan 29, 2019
Notification Of Final Refusal Emailed
Jan 29, 2019
Final Refusal E-Mailed
Jan 29, 2019
Final Refusal Written
Dec 22, 2018
Teas/Email Correspondence Entered
Dec 20, 2018
Correspondence Received In Law Office
Dec 20, 2018
Teas Response To Office Action Received
Jun 20, 2018
Notification Of Non-Final Action E-Mailed
Jun 20, 2018
Non-Final Action E-Mailed
Jun 20, 2018
Non-Final Action Written
Jun 12, 2018
Assigned To Examiner
Mar 8, 2018
New Application Office Supplied Data Entered
Mar 5, 2018
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24